Skip to main content
Article thumbnail
Location of Repository

Variations in captopril formulations used to treat children with heart failure: a survey in the United Kingdom.

By H. Mulla, M. Tofeig, F. Bu'Lock, Nilesh J. Samani and Hitesh C. Pandya


This is the version as published by BMJ Publishing Group. It is available online at and objective: Different liquid formulations of a drug prepared for use in children cannot be assumed to have therapeutic equivalence. The objective of this study was to ascertain the interhospital\ud constancy of unlicensed liquid captopril formulations used to treat children with heart failure in the UK.\ud Design: A questionnaire-based telephone survey.\ud Setting: 13 tertiary paediatric cardiac centres in the UK and 13 large hospitals referring patients to these centres.\ud Participants: The study included pharmacists responsible for providing the pharmaceutical input to children with congenital heart disease or a pharmacist designated to cover paediatric services. Technical staff\ud employed by ‘‘specials’’ manufacturers also participated.\ud Results: Four hospitals dispensed captopril tablets for crushing and dissolving in water before administration; the remaining 22 used nine different liquid formulations of captopril. Only three cardiac centres and their referring hospitals were found to be using the same liquid captopril formulations; 10 centres and their\ud referring hospitals were using completely different captopril formulations.\ud Conclusions: This survey shows that paediatric cardiac centres and their referring hospitals use a variety of\ud unlicensed liquid captopril formulations interchangeably. This degree of inconsistency raises issues about\ud optimal captopril dosing and potential toxicity, such that its use may influence paediatric cardiac surgical and interventional outcomes

Publisher: BMJ Publishing Group.
Year: 2007
OAI identifier:

Suggested articles


  1. Centre for Pharmacy Practice Research, Glenfield Hospital, Leicester,
  2. (1999). Dosage forms for peroral drug administration to children. Paediatr Perinatal Drug Ther
  3. (1986). Effect of dose formulation on isoniazid absorption in two young children. Pediatrics
  4. (2000). Factors influencing bioavailability.
  5. (2004). Formulation substitution: a frequently overlooked variable in cardiovascular drug management. Prog Cardiovasc Dis doi
  6. Heart failure in pediatric patients. Thorac Cardiovasc Surg doi
  7. (2001). Optimizing treatment for chronic congestive heart failure in children. Crit Care Med doi
  8. (2005). Paediatric formulations–getting to the heart of the problem. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.